Role of neuraminidase inhibitor chemoprophylaxis in controlling nosocomial influenza: An observational study

Influenza and other Respiratory Viruses

Volumn 6, Issue 4, 2012, Pages 299-303

  Higa, Futoshi ^a,b   Tateyama, Masao ^a,b   Tomishima, Miyuki ^b   Mukatake, Sakiko ^b   Yamashiro, Tsuyoshi ^b   Owan, Tomoko ^b   Haranaga, Shusaku ^a   Fujita, Jiro ^a,b  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Chemoprophylaxis; Infection control; Influenza; Neuraminidase inhibitor

Indexed keywords

OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CHILD; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL CARE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; CHEMOPREVENTION; CROSS INFECTION; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INFLUENZA, HUMAN; NEURAMINIDASE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRAL PROTEINS;

EID: 84862008491     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2011.00311.x     Document Type: Article

References (19)

1. CDC. Prevention strategies for seasonal influenza in healthcare settings. Available at (Accessed 11 July 2011).
2. Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings, 2007. Available at (Accessed 11 July 2011)
3. Carman WF, Elder AG, Wallace LA et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000; 355:93-97.
4. Harper SA, Bradley JS, Englund JA et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003-1032.
5. Ong AK, Hayden FG, John F. Enders lecture 2006: antivirals for influenza. J Infect Dis 2007; 196:181-190.
6. Khazeni N, Bravata DM, Holty JE, Uyeki TM, Stave CD, Gould MK. Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med 2009; 151:464-473.
7. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000; 355:827-835.
8. Hayden FG, Atmar RL, Schilling M et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999; 341:1336-1343.
9. Hayden FG, Treanor JJ, Fritz RS et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999; 282:1240-1246.
10. Bush KA, McAnulty J, McPhie K et al. Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. Commun Dis Intell 2004; 28:396-400.
11. Seale H, Weston KM, Dwyer DE et al. The use of oseltamivir during an influenza B outbreak in a chronic care hospital. Influenza Other Respi Viruses 2009; 3:15-20.
12. Shijubo N, Yamada G, Takahashi M, Tokunoh T, Suzuki T, Abe S. Experience with oseltamivir in the control of nursing home influenza A outbreak. Intern Med 2002; 41:366-370.
13. Peters PH Jr, Gravenstein S, Norwood P et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001; 49:1025-1031.
14. Harling R, Hayward A, Watson JM. Implications of the incidence of influenza-like illness in nursing homes for influenza chemoprophylaxis: descriptive study. BMJ 2004; 329:663-664.
15. Lee VJ, Yap J, Cook AR et al. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med 2010; 362:2166-2174.
16. Hsu EB, Millin MG. A hospital-based strategy for setting priorities for antiviral prophylaxis during an influenza pandemic. Biosecur Bioterror 2008; 6:171-178.
17. Garrison M, Welden L, Brantley P et al. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis - North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:969-972.
18. Gooskens J, Jonges M, Claas EC, Meijer A, van den Broek PJ, Kroes AM. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA 2009; 301:1042-1046.
19. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009; 361:2296-2297.